A Phase III study to compare the efficacy and safety of TachoSil and Surgicel Original as an adjunct to control mild to moderate soft tissue bleeding during surgery

16242CM-TS01OpenA Phase III study to compare the efficacy and safety of TachoSil and Surgicel Original as an adjunct to control mild to moderate soft tissue bleeding during surgeryNCT06664775IndustrialAdultTreatmentIIIGlobalOtherFabrizio, AnneGeorgetown University Medical Center; Lombardi Comprehensive Cancer CenterGUMC Surgery2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>